Skip to main content

OPT Industries

MaterialsMedford, USAFounded 2019· One of 1000 Materials companies tracked by AMPulse

A material foundry using digital photolithography to engineer microstructured materials with precise geometric control at micron-to-meter scales, delivering millions of parts across healthcare, cosmetics, industrial, and electronics/RF applications.

CEO / Founder
Jifei Ou
Team Size
11-50
Stage
Active
Total Funding
$35.1M
Latest Round
Series A
Key Investors
Northpond Ventures, Crosslink Capital, MIT E14 Fund

Technology & Products

Key Products

Roll-to-roll 3D printing technology, InstaSwab™ medical applicator, flockless applicators, false lashes, Freeforms P and T Series binder jet printers, high-precision metal printers.

Technical position · AMPulse analysis

Integrated OneProcess™ platform unifies in-house material development, computational design algorithms, and automated additive manufacturing, eliminating traditional manufacturing constraints and supply chain complexity. Technology enables 24/7 fully automated production of continuous 3D printed microstructures with customized geometries, reducing product development cycles from months to weeks while achieving superior performance characteristics.

Patent position

OPT Industries' equipment focus rose from 58% of its filed families in 2019 to 2021 to 89% in 2022 to 2024. Its 29 families in total trail well behind Velo3D's 84 and Desktop Metal's 102. AMPulse analysis

Filing momentum
13 families filed 2022–2024, 15 in 2019–2021
Focus, 2019–2021 → 2022–2024
Equipment 58% → 89%
Filed in
WO 38%US 34%EP 14%CN 14%
Named competitors, AM patent families
Velo3D 84Desktop Metal 102

29 AM patent families in total. Recent years are still being published, so read a filing change against the same-office figure.

Differentiation

Value Proposition

Unifies material development, computational design, and additive manufacturing into OneProcess platform, enabling creation of bioinspired metamaterials at scale with 25-50 micron precision while reducing supply chain complexity and accelerating time-to-market

How They Differentiate

Proprietary RAMP™ roll-to-roll digital photolithography 3D printing enabling continuous production of microstructures at unlimited lengths with 25-50 micron precision, combined with integrated OneProcess™ platform that unifies in-house material development, computational design, and automated additive manufacturing to create bioinspired metamaterials impossible to manufacture with traditional methods

Market & Competition

Target Customers

Healthcare providers and diagnostic companies, cosmetics brands, automotive manufacturers, consumer goods companies, and Fortune 500 enterprises requiring customized high-precision materials and products

Industry Verticals

Healthcare & Medical Devices, Cosmetics & Beauty, Automotive, Consumer Goods, Industrial Manufacturing, Diagnostics

Competitors

Velo3d, Carbon3D, Desktop Metal

Growth & Milestones

Growth Metrics

Scaled from MIT Media Lab spinout to commercial-stage company with 14,000 sqft manufacturing facility, 40-51 employees, and 24/7 fully automated production capability

Major Milestones

Founded as MIT Media Lab spinout in 2019, InstaSwab™ COVID-19 testing product deployed during pandemic (2020), 14,000 sqft manufacturing facility opened in Medford, MA, Series A funding led by Northpond Ventures (Mar 2022), Lumofil™ cosmetic applicator product line launched, 12+ patents filed covering RAMP™ technology and metamaterial designs

Notable Customers

Healthcare providers nationwide (InstaSwab™ deployment); Cosmetic brands (Lumofil™ mascara applicators); Industrial manufacturers (PolyBrush™ vibratory brushes); Fortune 500 companies across multiple sectors

https://optindustries.com

AM patents

AM-relevant patents linked to this company.

Patents
31
Granted
6
Families
29

Leading domains: process (29), equipment (16), software (12)

Filings by year: 2025: 1 · 2024: 2 · 2023: 3 · 2022: 8 · 2021: 14 · 2020: 3

  1. ADDITIVELY MANUFACTURED FALSE EYELASHES2025175058 · WO
  2. MULTI-POLYMER SYSTEMS FOR ADDITIVE MANUFACTURING2022251568 · WO
  3. Systems, methods and file format for 3D printing of microstructures11681269 · US
  4. CONTROL OF PHOTO-POLYMERIZATION FOR ADDITIVE MANUFACTURING20240262041 · US
  5. ADDITIVELY-MANUFACTURED SUBSTRATE FOR VIBRATORY CONVEYING2024112896 · WO

Funding rounds

  • Series A$15.0M2022-03Lead: Northpond Ventures · Source: PR Newswire, Crunchbase
  • Pre-Seed$1.5M2019-02Lead: MIT E14 Fund · Source: Crunchbase

Why this company matters

AMPulse analysis, not a company disclosure

OPT Industries occupies a unique niche at the intersection of computational design, materials science, and continuous additive manufacturing. Its proprietary RAMP roll-to-roll digital photolithography process enables the production of microstructured metamaterials at lengths not feasible with conventional vat photopolymerization systems. The company's OneProcess platform integrates material development, computational design algorithms, and automated 3D printing into a single workflow, reducing product development cycles from months to weeks.

The core technology uses VPP-DLP (vat photopolymerization digital light processing) in a continuous roll-to-roll format, achieving 25–50 micron precision. This allows OPT to fabricate bioinspired geometries—such as those found in its InstaSwab medical applicator and Lumofil mascara applicator—that cannot be produced via injection molding or traditional AM. The company operates a 14,000 sqft facility in Medford, Massachusetts, with 24/7 automated production capability and a team of 40–51 employees.

OPT targets healthcare, cosmetics, automotive, and industrial manufacturing customers. Its InstaSwab was deployed during the COVID-19 pandemic, and its flockless applicators and PolyBrush vibratory brushes serve cosmetic brands and industrial manufacturers. The company positions itself as a collaborative technology partner for Fortune 500 enterprises requiring customized high-precision polymer parts. Key investors include Northpond Ventures, Crosslink Capital, and the MIT E14 Fund, with $35.1 million in total funding raised as of its March 2022 Series A.

The primary competitive risk is whether roll-to-roll DLP can achieve the throughput and cost structure to displace incumbent processes like injection molding for high-volume applications. Competitors such as Carbon and Desktop Metal offer faster single-part printing but lack continuous-length capability. OPT's moat rests on its integrated materials-computation-manufacturing platform and the 12 patents filed around its RAMP technology and metamaterial designs.